The AGAMOUS (AG) gene is necessary for stamen and carpel development and is part of a monophyletic clade of MADS-box genes that also includes SHATTERPROOF1 (SHP1), SHP2, and SEEDSTICK (STK). Here, we show that ectopic expression of either the STK or SHP gene is sufficient to induce the transformation of sepals into carpeloid organs bearing ovules. Moreover, the fact that these organ transformat...

A new species of Lachemilla (Rosaceae), Lachemilla mexiquense D.F. Morales-B., from Mexico is described and illustrated. This species is similar to Lachemilla aphanoides by its tripartite leaves and glomerulate inflorescence with entirely glabrous flowers, but it differs by its stonoliferous habit, persistent basal leaves and basal stipules, and smaller flowers with a campanulate-elongate hypan...

Studies involving mutants of the gene SPATULA indicate that it promotes the growth of carpel margins and of pollen tract tissues derived from them. We show that it encodes a new member of the basic-helix-loop-helix family of transcription factors. SPATULA is expressed in marginal and pollen tract tissues throughout their development confirming its role in regulating their growth. It is also exp...

Members of the YABBY family of putative transcription factors participate in abaxial-adaxial identity determination in lateral organs in Arabidopsis (Arabidopsis thaliana). Two YABBY genes specifically expressed in reproductive structures, CRABS CLAW (CRC) and INNER NO OUTER (INO), have additional activities, with CRC promoting nectary development and carpel fusion, and INO responding to spatia...

MADS-box genes have been shown to play a role in the formation of fruits, both in Arabidopsis and in tomato. In peach, two C-class MADS-box genes have been isolated. Both of them are expressed during flower and mesocarp development. Here a detailed analysis of a gene that belongs to the PLENA subfamily of MADS-box genes is shown. The expression of this PLENA-like gene (PpPLENA) increases during...

Some diseases require medical mitigation following the diagnosis, and sometimes situation means that patient has to undertake strong medication. However, this medicine is designed pharmacodynamically interact with other organs before they reach intended organ. imposes challenges on involved While main organ will be healed, some drugs’ footprints left out organs. These are called iatrogenic inju...